REGN today
$951.19-$8.22 (-0.86%)close Nov 12, 2026Trend
DailyUptrend (confirmed)
4 hourBullish
1 hourBullish
15 minLeaning Bullish
5 minConsolidating
Daily trend turns down below $796.61
Key levels
Resistance$991.73
Resistance$952.30
Support$917.70
Support$887.04
Latest news & SEC filings
ProductRegeneron reports Phase 2 PINNACLE trial results for baloncibart in POTS
ProductAlnylam and Regeneron say CIDEB siRNA cut liver fat up to 80% for 36 weeks after one dose
All REGN news →About Regeneron
Regeneron Pharmaceuticals is a biotechnology company that discovers, develops, manufactures, and sells medicines for serious diseases. Its approved products treat eye conditions such as wet age-related macular degeneration and diabetic macular edema, inflammatory diseases including atopic dermatitis and asthma, several cancer types, cardiovascular conditions, and rare diseases. The company sells its medicines in the United States, Europe, Japan, and other markets, both directly and through collaborators such as Sanofi and Bayer.
Based on the company's 10-K filed Feb 4, 2026.
Nasdaq · Healthcare
REGENERON PHARMACEUTICALS, INC. (REGN)
What Is the Price Target for REGN?
SEPT Low Target
$740.00
SEPT Mid Target
$927.50
SEPT High Target
$1175.00
Analyst Consensus
$927.50
Is REGN a Buy or Sell Right Now?
Thesis
- •Revenue growing 1.0% YoY with STABLE trend — consistent growth.
AI-Powered Trading Signals
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for REGN.
Start Free Trial →Is REGN Overvalued or Undervalued?
Valuation Verdict
FAIR
Methods Used
P/E Forward, P/B, Analyst Consensus
Fair Value
$943.15
44
Moat Score
NARROW
4/9
Piotroski Score
8.8
Altman Z-Score
What Is Smart Money Doing with REGN?
Insider Signal
SELLING
0 buys / 20 sells (90d)
Congress Signal
BUYING
4 buys / 2 sells (90d)
Institutional
N/A
Short Squeeze Risk
MEDIUM
Signal: NEUTRAL
Recent Insider Activity
| Name | Title | Type | Shares | Value | Date |
|---|---|---|---|---|---|
| Pitofsky Jason | officer | Buy | 1,500 | $1.1M | Nov 4, 2026 |
| Pitofsky Jason | officer | Buy | 1,478 | $953K | Nov 4, 2026 |
| Pitofsky Jason | officer | Buy | 905 | $445K | Nov 4, 2026 |
| Pitofsky Jason | officer | Sale | 439 | $412K | Nov 4, 2026 |
| Pitofsky Jason | officer | Sale | 575 | $541K | Nov 4, 2026 |
| Pitofsky Jason | officer | Sale | 982 | $925K | Nov 4, 2026 |
| Pitofsky Jason | officer | Sale | 1,215 | $1.1M | Nov 4, 2026 |
| Pitofsky Jason | officer | Sale | 529 | $499K | Nov 4, 2026 |
| Pitofsky Jason | officer | Sale | 108 | $102K | Nov 4, 2026 |
| Pitofsky Jason | officer | Sale | 35 | $33K | Nov 4, 2026 |
Track Smart Money Across 4,000+ Stocks
Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.
See All Smart Money Signals →REGN Growth Story
Revenue YoY
1.0%
3yr Revenue CAGR
5.6%
EPS Growth YoY
8.19%
FCF Growth YoY
11.3%
Revenue Trend
STABLE
Dark Pool Trades for REGN
PREVIEWSEPT Investing tracks real-time dark pool institutional trades for REGN, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.
| Time | Price | Size | Value | Side |
|---|---|---|---|---|
| 22:24:27 | $951.19 | 158,320 | $$150.6M | BUY |
| 22:24:27 | $951.19 | 23,760 | $$22.6M | BUY |
| 21:00:24 | $951.19 | 1,037 | $$986K | BUY |
| 21:00:24 | $951.19 | 8,777 | $$8.3M | BUY |
| 21:00:24 | $951.19 | 1,233 | $$1.2M | BUY |
5 dark pool trades shown · $$183.7M preview volume
Real-time institutional flow, block trades, and net positioning
Options Flow for REGN
PREVIEWSEPT Investing provides real-time options flow tracking for REGN, including unusual sweep detection, block trades, and dealer positioning. Each trade shows strike, expiry, premium, implied volatility, and greek values for informed decision-making.
| Type | Strike | Expiry | DTE | Premium | Size | Trade |
|---|---|---|---|---|---|---|
| CALL | $300 | Jan 21 | 435 | $$137.2K | 2 | FLOOR |
| CALL | $1040 | Dec 18 | 36 | $$1340 | 1 | SWEEP |
| CALL | $1040 | Dec 18 | 36 | $$9380 | 7 | SWEEP |
| CALL | $1040 | Dec 18 | 36 | $$1340 | 1 | SWEEP |
| CALL | $1040 | Dec 18 | 36 | $$8040 | 6 | SWEEP |
5 options trades shown · 100% calls
Unusual activity, GEX levels, max pain, and dealer positioning
Full AI Research Report
SEPT's Trading AI has generated a free, downloadable PDF research report for REGENERON PHARMACEUTICALS, INC. (REGN) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.
Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (2 articles analyzed), and SEC filing intelligence...
AI-Powered Trading Signals.
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.
Try SEPT Free for 7 Days →REGN — frequently asked questions
What is REGN stock price today?
REGENERON PHARMACEUTICALS, INC. (REGN) is at $951.19, down 0.86% (-$8.22) at the Nov 12, 2026 close.
Why is REGN stock moving today?
Latest REGN news — Nov 12, 2026: Regeneron reports Phase 2 PINNACLE trial results for baloncibart in POTS · Nov 10, 2026: Alnylam and Regeneron say CIDEB siRNA cut liver fat up to 80% for 36 weeks after one dose
What is the REGN price target?
The average analyst price target for REGN is $927.50, ranging from $740 to $1175, based on 22 analysts. Latest: B of A Securities maintains on Nov 2, 2026.
What do analysts rate REGN?
Analyst ratings for REGN: 2 Buy, 48 Hold, 2 Sell — consensus Hold.
Did REGN beat earnings?
REGN last reported on Oct 30, 2026: EPS $20.07 vs $16.42 expected — a beat of 22.2%.
What is REGN's P/E ratio?
REGN trades at a P/E of 21.4 vs a Healthcare average of 17.8.
Does REGN pay a dividend?
Yes. REGN's dividend yield is 0.46%.
What are REGN support and resistance levels?
Support: $917.70, $887.04, $847.00. Resistance: $952.30, $991.73, $1024.36.
What are insiders doing with REGN?
Insider activity: SELLING, 0 buys and 20 sells in the last 90 days.
What is the latest news on REGN?
Nov 12, 2026: Regeneron reports Phase 2 PINNACLE trial results for baloncibart in POTS · Nov 10, 2026: Alnylam and Regeneron say CIDEB siRNA cut liver fat up to 80% for 36 weeks after one dose